A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277 - 300; http://dx.doi.org/10.3322/caac.20073; PMID: 20610543
   PubMed Web of Science ®Google Scholar
• Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn 2010; 10:297 - 308; http://dx.doi.org/10.1586/erm.10.11; PMID: 20370587
   PubMed Web of Science ®Google Scholar
• Garofalo M, Condorelli G, Croce CM. MicroRNAs in diseases and drug response. Curr Opin Pharmacol 2008; 8:661 - 7; http://dx.doi.org/10.1016/j.coph.2008.06.005; PMID: 18619557
   PubMed Web of Science ®Google Scholar
• Hummel R, Hussey DJ, Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 2010; 46:298 - 311; http://dx.doi.org/10.1016/j.ejca.2009.10.027; PMID: 19948396
   PubMed Web of Science ®Google Scholar
• Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 2006; 103:4034 - 9; http://dx.doi.org/10.1073/pnas.0510928103; PMID: 16495412
   PubMed Web of Science ®Google Scholar
• Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466:835 - 40; http://dx.doi.org/10.1038/nature09267; PMID: 20703300
   PubMed Web of Science ®Google Scholar
• Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 2007; 6:5; http://dx.doi.org/10.1186/1476-4598-6-5; PMID: 17222355
   PubMed Web of Science ®Google Scholar
• Lee DY, Deng Z, Wang CH, Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 2007; 104:20350 - 5; http://dx.doi.org/10.1073/pnas.0706901104; PMID: 18077375
   PubMed Web of Science ®Google Scholar
• O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435:839 - 43; http://dx.doi.org/10.1038/nature03677; PMID: 15944709
   PubMed Web of Science ®Google Scholar
• Ma J, Dong C, Ji C. MicroRNA and drug resistance. Cancer Gene Ther 2010; 17:523 - 31; http://dx.doi.org/10.1038/cgt.2010.18; PMID: 20467450
   PubMed Web of Science ®Google Scholar
• Zheng T, Wang J, Chen X, Liu L. Role of microRNA in anticancer drug resistance. Int J Cancer 2010; 126:2 - 10; http://dx.doi.org/10.1002/ijc.24782; PMID: 19634138
   PubMed Web of Science ®Google Scholar
• Enfield KS, Stewart GL, Pikor LA, Alvarez CE, Lam S, Lam WL, Chari R. MicroRNA gene dosage alterations and drug response in lung cancer. J Biomed Biotechnol 2011; 2011:474632; http://dx.doi.org/10.1155/2011/474632; PMID: 21541180
   PubMed Web of Science ®Google Scholar
• Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 2007; 67:8994 - 9000; http://dx.doi.org/10.1158/0008-5472.CAN-07-1045; PMID: 17908999
   PubMed Web of Science ®Google Scholar
• Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H, Yamada H, Suzuki M, Nagino M, Nimura Y, et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 2007; 26:6099 - 105; http://dx.doi.org/10.1038/sj.onc.1210425; PMID: 17384677
   PubMed Web of Science ®Google Scholar
• Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M, Boldrini R, Donfrancesco A, Federici V, Giacomini P, et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008; 3:e2236; http://dx.doi.org/10.1371/journal.pone.0002236; PMID: 18493594
   PubMed Web of Science ®Google Scholar
• Davis S, Lollo B, Freier S, Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 2006; 34:2294 - 304; http://dx.doi.org/10.1093/nar/gkl183; PMID: 16690972
   PubMed Web of Science ®Google Scholar
• Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, Minna JD, Michnoff C, Hao W, Roth MG, et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007; 446:815 - 9; http://dx.doi.org/10.1038/nature05697; PMID: 17429401
   PubMed Web of Science ®Google Scholar
• Lam LT, Lu X, Zhang H, Lesniewski R, Rosenberg S, Semizarov D. A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax). Mol Cancer Ther 2010; 9:2943 - 50; http://dx.doi.org/10.1158/1535-7163.MCT-10-0427; PMID: 20829195
   PubMed Web of Science ®Google Scholar
• Izumiya M, Okamoto K, Tsuchiya N, Nakagama H. Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs. Carcinogenesis 2010; 31:1354 - 9; http://dx.doi.org/10.1093/carcin/bgq112; PMID: 20525881
   PubMed Web of Science ®Google Scholar
• Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 1995; 47:331 - 85; PMID: 7568331
   PubMed Web of Science ®Google Scholar
• Krokan H, Wist E, Krokan RH. Aphidicolin inhibits DNA synthesis by DNA polymerase alpha and isolated nuclei by a similar mechanism. Nucleic Acids Res 1981; 9:4709 - 19; http://dx.doi.org/10.1093/nar/9.18.4709; PMID: 6795595
   PubMed Web of Science ®Google Scholar
• Kota KP, Benko JG, Mudhasani R, Retterer C, Tran JP, Bavari S, Panchal RG. High content image based analysis identifies cell cycle inhibitors as regulators of Ebola virus infection. Viruses 2012; 4:1865 - 77; http://dx.doi.org/10.3390/v4101865; PMID: 23202445
   PubMed Web of Science ®Google Scholar
• Zhu Y, Alvarez C, Doll R, Kurata H, Schebye XM, Parry D, Lees E. Intra-S-phase checkpoint activation by direct CDK2 inhibition. Mol Cell Biol 2004; 24:6268 - 77; http://dx.doi.org/10.1128/MCB.24.14.6268-6277.2004; PMID: 15226429
   PubMed Web of Science ®Google Scholar
• Smith J, Tho LM, Xu N, Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 2010; 108:73 - 112; http://dx.doi.org/10.1016/B978-0-12-380888-2.00003-0; PMID: 21034966
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92 - 105; http://dx.doi.org/10.1101/gr.082701.108; PMID: 18955434
   PubMed Web of Science ®Google Scholar
• Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, Weidhaas JB, Bader AG, Slack FJ. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 2011; 19:1116 - 22; http://dx.doi.org/10.1038/mt.2011.48; PMID: 21427705
   PubMed Web of Science ®Google Scholar
• Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D, Bader AG. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 2010; 70:5923 - 30; http://dx.doi.org/10.1158/0008-5472.CAN-10-0655; PMID: 20570894
   PubMed Web of Science ®Google Scholar
• Crawford M, Batte K, Yu L, Wu X, Nuovo GJ, Marsh CB, Otterson GA, Nana-Sinkam SP. MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun 2009; 388:483 - 9; http://dx.doi.org/10.1016/j.bbrc.2009.07.143; PMID: 19654003
   PubMed Web of Science ®Google Scholar
• Xie T, Liang J, Guo R, Liu N, Noble PW, Jiang D. Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 2011; 43:479 - 87; http://dx.doi.org/10.1152/physiolgenomics.00222.2010; PMID: 21266501
   PubMed Web of Science ®Google Scholar
• Li ZY, Na HM, Peng G, Pu J, Liu P. Alteration of microRNA expression correlates to fatty acid-mediated insulin resistance in mouse myoblasts. Mol Biosyst 2011; 7:871 - 7; http://dx.doi.org/10.1039/c0mb00230e; PMID: 21183973
   PubMed Web of Science ®Google Scholar
• Semaan N, Frenzel L, Alsaleh G, Suffert G, Gottenberg JE, Sibilia J, Pfeffer S, Wachsmann D. miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization. PLoS One 2011; 6:e19827; http://dx.doi.org/10.1371/journal.pone.0019827; PMID: 21611196
   PubMed Web of Science ®Google Scholar
• Alsaleh G, Suffert G, Semaan N, Juncker T, Frenzel L, Gottenberg JE, Sibilia J, Pfeffer S, Wachsmann D. Bruton’s tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblast-like synoviocytes. J Immunol 2009; 182:5088 - 97; http://dx.doi.org/10.4049/jimmunol.0801613; PMID: 19342689
   PubMed Web of Science ®Google Scholar
• Bartoszewski R, Brewer JW, Rab A, Crossman DK, Bartoszewska S, Kapoor N, Fuller C, Collawn JF, Bebok Z. The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. J Biol Chem 2011; 286:41862 - 70; http://dx.doi.org/10.1074/jbc.M111.304956; PMID: 22002058
   PubMed Web of Science ®Google Scholar
• Tsai NP, Lin YL, Wei LN. MicroRNA mir-346 targets the 5′-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression. Biochem J 2009; 424:411 - 8; http://dx.doi.org/10.1042/BJ20090915; PMID: 19780716
   PubMed Web of Science ®Google Scholar
• Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 2006; 91:3584 - 91; http://dx.doi.org/10.1210/jc.2006-0693; PMID: 16822819
   PubMed Web of Science ®Google Scholar
• Ricci MS, Zong WX. Chemotherapeutic approaches for targeting cell death pathways. Oncologist 2006; 11:342 - 57; http://dx.doi.org/10.1634/theoncologist.11-4-342; PMID: 16614230
   PubMed Web of Science ®Google Scholar
• Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432:316 - 23; http://dx.doi.org/10.1038/nature03097; PMID: 15549093
   PubMed Web of Science ®Google Scholar
• Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 2004; 5:792 - 804; http://dx.doi.org/10.1038/nrm1493; PMID: 15459660
   PubMed Web of Science ®Google Scholar
• Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY, Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 2002; 16:571 - 82; http://dx.doi.org/10.1101/gad.970702; PMID: 11877377
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, Lane WS, Kastan MB, D’Andrea AD. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 2002; 109:459 - 72; http://dx.doi.org/10.1016/S0092-8674(02)00747-X; PMID: 12086603
   PubMed Web of Science ®Google Scholar
• Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, Mathew CG, Kastan MB, Weaver DT, D’Andrea AD. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 2002; 4:913 - 20; http://dx.doi.org/10.1038/ncb879; PMID: 12447395
   PubMed Web of Science ®Google Scholar
• Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366:883 - 92; http://dx.doi.org/10.1056/NEJMoa1113205; PMID: 22397650
   PubMed Web of Science ®Google Scholar
• Lee AJ, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ, Futreal PA, Downward J, Szallasi Z, Tomlinson IP, Howell M, et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res 2011; 71:1858 - 70; http://dx.doi.org/10.1158/0008-5472.CAN-10-3604; PMID: 21363922
   PubMed Web of Science ®Google Scholar
• Bookout AL, Mangelsdorf DJ. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl Recept Signal 2003; 1:e012; http://dx.doi.org/10.1621/nrs.01012; PMID: 16604184
   PubMedGoogle Scholar
• Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 2009; 7:1234 - 43; http://dx.doi.org/10.1158/1541-7786.MCR-08-0507; PMID: 19671678
   PubMed Web of Science ®Google Scholar
• Du L, Subauste MC, DeSevo C, Zhao Z, Baker M, Borkowski R, Schageman JJ, Greer R, Yang CR, Suraokar M, et al. miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PLoS One 2012; 7:e39167; http://dx.doi.org/10.1371/journal.pone.0039167; PMID: 22723956
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15 - 20; http://dx.doi.org/10.1016/j.cell.2004.12.035; PMID: 15652477
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19:92 - 105; http://dx.doi.org/10.1101/gr.082701.108; PMID: 18955434
   PubMed Web of Science ®Google Scholar
• Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27:91 - 105; http://dx.doi.org/10.1016/j.molcel.2007.06.017; PMID: 17612493
   PubMed Web of Science ®Google Scholar
• Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 2011; 18:1139 - 46; http://dx.doi.org/10.1038/nsmb.2115; PMID: 21909094
   PubMed Web of Science ®Google Scholar
• Bluemn EG, Spencer ES, Mecham B, Gordon RR, Coleman I, Lewinshtein D, et al. PPP2R2C loss promotes castration-resistant prostate cancer growth and is associated with increased prostate cancer-specific mortality. Mol Cancer Res 2013; 11:6 568 - 78; http://dx.doi.org/10.1158/1541-7786.MCR-12-0710; PMID: 23493267
   PubMed Web of Science ®Google Scholar
• Barceló-Coblijn G, Martin ML, de Almeida RF, Noguera-Salvà MA, Marcilla-Etxenike A, Guardiola-Serrano F, Lüth A, Kleuser B, Halver JE, Escribá PV. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy. Proc Natl Acad Sci U S A 2011; 108:19569 - 74; http://dx.doi.org/10.1073/pnas.1115484108; PMID: 22106271
   PubMed Web of Science ®Google Scholar
• Huang J, Yan J, Zhang J, Zhu S, Wang Y, Shi T, Zhu C, Chen C, Liu X, Cheng J, et al. SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane. Nat Commun 2012; 3:911; http://dx.doi.org/10.1038/ncomms1919; PMID: 22713753
   PubMed Web of Science ®Google Scholar
• Marin MB, Ghenea S, Spiridon LN, Chiritoiu GN, Petrescu AJ, Petrescu SM. Tyrosinase degradation is prevented when EDEM1 lacks the intrinsically disordered region. PLoS One 2012; 7:e42998; http://dx.doi.org/10.1371/journal.pone.0042998; PMID: 22905195
   PubMedGoogle Scholar
• Li Y, Li W, Yang Y, Lu Y, He C, Hu G, Liu H, Chen J, He J, Yu H. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 2009; 1286:13 - 8; http://dx.doi.org/10.1016/j.brainres.2009.06.053; PMID: 19559015
   PubMed Web of Science ®Google Scholar
• Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D, Zhang Y. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 2010; 45:17 - 23; http://dx.doi.org/10.1007/s00535-009-0135-6; PMID: 19802518
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Wei L, Liu M, Li J, Zheng YQ, Gao Y, Li XR. BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells. Tumour Biol 2013; 34:1605 - 13; http://dx.doi.org/10.1007/s13277-013-0691-5; PMID: 23420441
   PubMed Web of Science ®Google Scholar
• Madan E, Gogna R, Kuppusamy P, Bhatt M, Pati U, Mahdi AA. TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex. Br J Cancer 2012; 107:516 - 26; http://dx.doi.org/10.1038/bjc.2012.260; PMID: 22782351
   PubMed Web of Science ®Google Scholar
• Zhang S, Jiang T, Feng L, Sun J, Lu H, Wang Q, Pan M, Huang D, Wang X, Wang L, et al. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha. J Mol Med (Berl) 2012; 90:1069 - 77; http://dx.doi.org/10.1007/s00109-012-0879-y; PMID: 22391813
   PubMed Web of Science ®Google Scholar
• Caldeira J, Simões-Correia J, Paredes J, Pinto MT, Sousa S, Corso G, Marrelli D, Roviello F, Pereira PS, Weil D, et al. CPEB1, a novel gene silenced in gastric cancer: a Drosophila approach. Gut 2012; 61:1115 - 23; http://dx.doi.org/10.1136/gutjnl-2011-300427; PMID: 22052064
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xu Z, Wang X, Wang H, Yao Z, Mu Y, Ma Z, Liu Z. Ectopic Ikaros expression positively correlates with lung cancer progression. Anat Rec (Hoboken) 2013; 296:907 - 13; http://dx.doi.org/10.1002/ar.22700; PMID: 23580163
   PubMedGoogle Scholar
• Choi HS, Bode AM, Shim JH, Lee SY, Dong Z. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer. Mol Cell Biol 2009; 29:2168 - 80; http://dx.doi.org/10.1128/MCB.01508-08; PMID: 19204086
   PubMed Web of Science ®Google Scholar
• auf dem Keller U, Huber M, Beyer TA, Kümin A, Siemes C, Braun S, Bugnon P, Mitropoulos V, Johnson DA, Johnson JA, et al. Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing. Mol Cell Biol 2006; 26:3773 - 84; http://dx.doi.org/10.1128/MCB.26.10.3773-3784.2006; PMID: 16648473
   PubMed Web of Science ®Google Scholar
• Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr.. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 2008; 112:1489 - 502; http://dx.doi.org/10.1002/cncr.23323; PMID: 18286529
   PubMed Web of Science ®Google Scholar
• Harada N, Yokoyama T, Yamaji R, Nakano Y, Inui H. RanBP10 acts as a novel coactivator for the androgen receptor. Biochem Biophys Res Commun 2008; 368:121 - 5; http://dx.doi.org/10.1016/j.bbrc.2008.01.072; PMID: 18222118
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang Y, Yeh S, Chang C. ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation. Mol Cell Biol 2004; 24:1044 - 57; http://dx.doi.org/10.1128/MCB.24.3.1044-1057.2004; PMID: 14729952
   PubMed Web of Science ®Google Scholar
• Yu SJ, Hu JY, Kuang XY, Luo JM, Hou YF, Di GH, Wu J, Shen ZZ, Song HY, Shao ZM. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer. Clin Cancer Res 2013; 19:1389 - 99; http://dx.doi.org/10.1158/1078-0432.CCR-12-1959; PMID: 23340296
   PubMed Web of Science ®Google Scholar
• Wong JS, Iorns E, Rheault MN, Ward TM, Rashmi P, Weber U, Lippman ME, Faul C, Mlodzik M, Mundel P. Rescue of tropomyosin deficiency in Drosophila and human cancer cells by synaptopodin reveals a role of tropomyosin α in RhoA stabilization. EMBO J 2012; 31:1028 - 40; http://dx.doi.org/10.1038/emboj.2011.464; PMID: 22157816
   PubMed Web of Science ®Google Scholar
• Sun H, Jiang L, Luo X, Jin W, He Q, An J, Lui K, Shi J, Rong R, Su W, et al. Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer. Oncogene 2013; 32:234 - 41; http://dx.doi.org/10.1038/onc.2012.34; PMID: 22349814
   PubMed Web of Science ®Google Scholar
• Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene 2012; 31:776 - 86; http://dx.doi.org/10.1038/onc.2011.266; PMID: 21725364
   PubMed Web of Science ®Google Scholar
• Williams YN, Masuda M, Sakurai-Yageta M, Maruyama T, Shibuya M, Murakami Y. Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4. Oncogene 2006; 25:1446 - 53; http://dx.doi.org/10.1038/sj.onc.1209192; PMID: 16261159
   PubMed Web of Science ®Google Scholar